Dr Andrew Buchanan
- Head of Discovery
Research
Research interests span drug discovery, disease biology, and translational pharmacology in immune dysfunction or chronic inflammation patient settings. Work focuses on biologics targeted therapeutics. Interested in human translational models, antibody & peptide therapeutics, and the use of integrated preclinical and clinical data to inform therapeutic innovation.